Please sign in with your existing account details.
Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.
Privacy statement - Terms and conditions
Forgotten your password?
You have exceeded the maximum number of login attempts for this email address and your account has been locked. An email has been sent to member of Browne Jacobson's web team and some one will be contacting you over the next two working days with details of how to change your password.
Are you sure you want to remove this item from you pinned content?
A survey of school leaders shows that the majority are dissatisfied with the DfE and Ofsted. The survey set out that over 75% of respondents expressed dissatisfaction with the DfE over its performance in education. This is an increase from the same question posed in 2010. Respondents were equally unhappy with Ofsted with over 60% expressing a view that Ofsted judgements were inaccurate although the views altered if their own school was judged. School leaders in good or outstanding schools were more likely to agree with the Ofsted findings. The survey results also showed that nearly half of the respondents felt that standards had improved since the government came to power.
The results show a mixed reaction to the DfE and Ofsted. The view that standards are rising is clearly good news for all but the dissatisfaction with the DfE and Ofsted may be a cause for concern – although that may be linked to the greater scrutiny on schools which, in turn, may be a reason leading to higher standards overall.
With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.
View blog
The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.
Our top tips for supporting transgender and non-binary pupils.
On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.
Partner
Select which mailings you would like to receive from us.
Sign up